Turning a corner on HIV neutralization?

Jack H. Nunberg, Kathryn E. Follis, Meg Trahey, Rachel A. Lacasse

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


HIV vaccine development has been hampered by the inability of conventional immunogens to elicit antibodies capable of neutralizing primary isolates of the virus. Recent studies using 'fusion-competent' immunogens that capture transitional intermediate structures of the functioning envelope protein suggest that this goal may now be achievable. (C) 2000 Editions scientifiques et medicales Elsevier SAS.

Original languageEnglish
Pages (from-to)213-221
Number of pages9
JournalMicrobes and Infection
Issue number2
StatePublished - Feb 2000


  • Antibodies
  • Envelope protein
  • Fusion
  • Human immunodeficiency virus
  • Vaccines
  • Virus neutralization


Dive into the research topics of 'Turning a corner on HIV neutralization?'. Together they form a unique fingerprint.

Cite this